Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.
about
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders.Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis.Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.ADHD Medication and Substance-Related Problems.Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review.Psychostimulant drugs for cocaine dependence.Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review.Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study.Patterns and profiles of Methylphenidate use in both children and adults.International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
P2860
Q33858264-0C2B5622-28DE-49AD-A42D-52E48843BE04Q33919571-5DCB3435-867A-402E-94F2-0E2662F349C9Q33919950-E79F4710-D934-4A45-8BF6-53B18F8F478EQ34497314-4D0F6BD1-86EE-43CA-8575-F74E32B60E3CQ35685121-B8F5C17A-E26A-45AE-B5CA-0E261E638F25Q36813731-1EF855B9-5E63-4E04-B86B-635D87663C7EQ38251282-FAAE4FAE-22F0-417E-921D-59341A8AAD6EQ38468989-A1B0D660-63F2-4C86-8A04-18CB299B1B91Q38569727-42573611-76E0-48E3-AF01-E426BD302AC4Q38665501-AAD84AC2-E04A-4986-A95B-63ECF1FCB366Q38714397-77B96FBF-9114-48C3-A872-521746B3F74BQ38964799-DA12DCFE-0D2D-4D24-9100-284D3DAD1B07Q39043767-52B77EED-E032-498E-8AB7-FC756CA133D1Q39154027-9EBB4A72-0237-4EA1-BB05-1F3665B6E07BQ39170905-4570A316-4ACD-467D-BBDF-FAF0DFE7856EQ43075919-1FF7DFCA-EF88-400B-B053-E2D02CB3E8D4Q47437318-D331DF3A-67BE-4697-9020-EB19AE2CA8BDQ51411756-84A72A49-2B4A-452E-8305-581B377E1DE6Q55339438-F9F597D8-3718-4889-9C6A-7EDBB2461B27
P2860
Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pharmacological treatment of a ...... ith co-morbid drug dependence.
@en
type
label
Pharmacological treatment of a ...... ith co-morbid drug dependence.
@en
prefLabel
Pharmacological treatment of a ...... ith co-morbid drug dependence.
@en
P2860
P356
P1476
Pharmacological treatment of a ...... with co-morbid drug dependence
@en
P2093
P2860
P356
10.1177/0269881114544777
P407
P577
2014-08-20T00:00:00Z